The NHS prescribes GLP-1 injections only if you have type 2 diabetes or heart disease, not for weight loss alone
The answer is too often ask another specialist or your PCP when patients enquire about access because sorting it out is too complicated
The Ozempic SmPC notes that despite this effect, there is no clinically relevant impact on the absorption of most orally administered medications
Short acting GLP-1 RAs induce a substantial retardation in gastric emptying, which likely contributes significantly to the lowering of postprandial glucose excursions after meals when they are administered (282)
A: A typical starting dose is 1,0002,000 mcg once or twice per week
found that tezepatide had a significant dose-dependent advantage in weight loss compared with placebo, GLP-1R agonists, and basal insulin (130)